| # | Holder | Shares | % of Shares Out | Change | Filing Date |
|---|---|---|---|---|---|
| 1 |
Wu (Jinzi Jason)
|
491.969m | 49.60% | — | Feb 10 2026 |
| 2 |
Wu (Hejingdao Judy)
|
83.983m | 8.47% | — | Feb 10 2026 |
| 3 |
GIC Private Limited
|
74.808m | 7.54% | +10.680m | May 07 2026 |
| 4 |
JJW11 Ltd
|
61.327m | 6.18% | -1.363m | Dec 31 2024 |
| 5 |
CBC Investment Twelve Ltd
|
45.808m | 4.62% | -4.922m | Apr 02 2025 |
|
1
Wu (Jinzi Jason)
|
49.60%
491.969m
|
|
2
Wu (Hejingdao Judy)
|
8.47%
83.983m
|
|
3
GIC Private Limited
|
7.54%
74.808m
|
|
4
JJW11 Ltd
|
6.18%
61.327m
|
|
5
CBC Investment Twelve Ltd
|
4.62%
45.808m
|
| The largest shareholders show who really holds influence: big institutional owners shape a stock's liquidity, and building or cutting positions can move the price. | |
| The 5 largest shareholders together hold 76.41% of Ascletis Pharma Inc, with Wu (Jinzi Jason) the biggest at 49.60%, followed by Wu (Hejingdao Judy) (8.47%) and GIC Private Limited (7.54%). |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


